comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists outcome studies receptor Association of glucagon-like peptide-1 receptor

[1] These medications work by mimicking the action of naturally occurring GLP-1, an incretin hormone that stimulates insulin secretion in response to food intake, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways

Global, regional, and national epidemiology of migraine and tension-type headache in youths and young adults aged 1539 years from 1990 to 2019: findings from the global burden of disease study 2019

Data were obtained from literature mining and the rates of body weight change from the initial values were selected as the therapeutic index

J.XiangJ

Drugs 14 , 10471054 (2005)